Trial NCT00945269

View at ClinicalTrials.gov 
Org. Study IDs: 2271.00
Secondary IDs: K12CA076930 NCI-2010-00738 R21CA137647

Last trial update was posted on 2022-11-15

MeSH Interventions

Aldesleukin Denileukin diftitox Immunotoxins Interleukin-2

MeSH Conditions

Melanoma

Other Conditions

Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Stopping Reasons

ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer be supporting clinical trials that utilize this drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID